Product Details for NDA 009698
MILTOWN (MEPROBAMATE)
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MEPROBAMATE
Proprietary Name: MILTOWN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N009698
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
MILTOWN (MEPROBAMATE)
Proprietary Name: MILTOWN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N009698
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MEPROBAMATE
Proprietary Name: MILTOWN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N009698
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: MILTOWN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N009698
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information